Literature DB >> 20412798

Efficacy of S-adenosylhomocysteine hydrolase inhibitors, D-eritadenine and (S)-DHPA, against the growth of Cryptosporidium parvum in vitro.

Vlasta Ctrnáctá1, Jason M Fritzler, Mária Surinová, Ivan Hrdý, Guan Zhu, Frantisek Stejskal.   

Abstract

D-eritadenine and (S)-DHPA are aliphatic adenosine analogues known to target S-adenosylhomocysteine hydrolase (SAHH) and potent antiviral compounds. In the present study, we demonstrate that these two compounds also display efficacy against recombinant SAHH enzyme of the protozoan parasite Cryptosporidium parvum, as well as inhibition of parasite growth in vitro. Our data confirm that SAHH could serve as a rational drug target in cryptosporidial infection and antiviral adenosine analogues are potential candidates for drug development against cryptosporidiosis. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20412798      PMCID: PMC2914804          DOI: 10.1016/j.exppara.2010.04.007

Source DB:  PubMed          Journal:  Exp Parasitol        ISSN: 0014-4894            Impact factor:   2.011


  25 in total

Review 1.  Cryptosporidium and cryptosporidiosis.

Authors:  R C A Thompson; M E Olson; G Zhu; S Enomoto; Mitchell S Abrahamsen; N S Hijjawi
Journal:  Adv Parasitol       Date:  2005       Impact factor: 3.870

2.  Three-dimensional structure of S-adenosyl-L-homocysteine hydrolase from Plasmodium falciparum.

Authors:  Nobutada Tanaka; Masayuki Nakanishi; Yoshio Kusakabe; Katsura Shiraiwa; Saori Yabe; Yasutomo Ito; Yukio Kitade; Kazuo T Nakamura
Journal:  Nucleic Acids Symp Ser (Oxf)       Date:  2004

3.  (S)-9-(2,3-Dihydroxypropyl)adenine: An Aliphatic Nucleoside Analog with Broad-Spectrum Antiviral Activity.

Authors:  E DE Clercq; J Descamps; P DE Somer; A Holyacute
Journal:  Science       Date:  1978-05-05       Impact factor: 47.728

Review 4.  The discovery of antiviral agents: ten different compounds, ten different stories.

Authors:  Erik De Clercq
Journal:  Med Res Rev       Date:  2008-11       Impact factor: 12.944

5.  Application of quantitative real-time reverse transcription-PCR in assessing drug efficacy against the intracellular pathogen Cryptosporidium parvum in vitro.

Authors:  Xiaomin Cai; Keith M Woods; Steve J Upton; Guan Zhu
Journal:  Antimicrob Agents Chemother       Date:  2005-11       Impact factor: 5.191

6.  Inhibition of S-adenosylhomocysteine hydrolase by acyclic sugar adenosine analogue D-eritadenine. Crystal structure of S-adenosylhomocysteine hydrolase complexed with D-eritadenine.

Authors:  Yafei Huang; Junichi Komoto; Yoshimi Takata; Douglas R Powell; Tomoharu Gomi; Hirofumi Ogawa; Motoji Fujioka; Fusao Takusagawa
Journal:  J Biol Chem       Date:  2001-12-10       Impact factor: 5.157

7.  Novel adenosine analogues with broad-spectrum biological activity: structure and mechanism of action.

Authors:  A Holý
Journal:  Nucleic Acids Symp Ser       Date:  1982

8.  The genome of Cryptosporidium hominis.

Authors:  Ping Xu; Giovanni Widmer; Yingping Wang; Luiz S Ozaki; Joao M Alves; Myrna G Serrano; Daniela Puiu; Patricio Manque; Donna Akiyoshi; Aaron J Mackey; William R Pearson; Paul H Dear; Alan T Bankier; Darrell L Peterson; Mitchell S Abrahamsen; Vivek Kapur; Saul Tzipori; Gregory A Buck
Journal:  Nature       Date:  2004-10-28       Impact factor: 49.962

9.  Effects of select medium supplements on in vitro development of Cryptosporidium parvum in HCT-8 cells.

Authors:  S J Upton; M Tilley; D B Brillhart
Journal:  J Clin Microbiol       Date:  1995-02       Impact factor: 5.948

10.  Characterization of S-adenosylhomocysteine hydrolase from Cryptosporidium parvum.

Authors:  Vlasta Ctrnáctá; Frantisek Stejskal; Janet S Keithly; Ivan Hrdý
Journal:  FEMS Microbiol Lett       Date:  2007-06-07       Impact factor: 2.742

View more
  5 in total

1.  Luciferase-based assay for adenosine: application to S-adenosyl-L-homocysteine hydrolase.

Authors:  Emmanuel S Burgos; Shivali A Gulab; María B Cassera; Vern L Schramm
Journal:  Anal Chem       Date:  2012-03-28       Impact factor: 6.986

2.  Effects of the Chinese medicine matrine on experimental C. parvum infection in BALB/c mice and MDBK cells.

Authors:  Fu Chen; Kehe Huang
Journal:  Parasitol Res       Date:  2012-07-11       Impact factor: 2.289

3.  The Cryptosporidium parvum kinome.

Authors:  Jennifer D Artz; Amy K Wernimont; Abdellah Allali-Hassani; Yong Zhao; Mehrnaz Amani; Yu-Hui Lin; Guillermo Senisterra; Gregory A Wasney; Oleg Fedorov; Oliver King; Annette Roos; Vlad V Lunin; Wei Qiu; Patrick Finerty; Ashley Hutchinson; Irene Chau; Frank von Delft; Farrell MacKenzie; Jocelyne Lew; Ivona Kozieradzki; Masoud Vedadi; Matthieu Schapira; Chao Zhang; Kevan Shokat; Tom Heightman; Raymond Hui
Journal:  BMC Genomics       Date:  2011-09-30       Impact factor: 3.969

4.  H19 lncRNA alters DNA methylation genome wide by regulating S-adenosylhomocysteine hydrolase.

Authors:  Jichun Zhou; Lihua Yang; Tianyu Zhong; Martin Mueller; Yi Men; Na Zhang; Juanke Xie; Karolyn Giang; Hunter Chung; Xueguang Sun; Lingeng Lu; Gordon G Carmichael; Hugh S Taylor; Yingqun Huang
Journal:  Nat Commun       Date:  2015-12-21       Impact factor: 14.919

5.  Quantitative RT-PCR assay for high-throughput screening (HTS) of drugs against the growth of Cryptosporidium parvum in vitro.

Authors:  Haili Zhang; Guan Zhu
Journal:  Front Microbiol       Date:  2015-09-22       Impact factor: 5.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.